Physician profile
Laura E Sheffer
NPI 1063446789
$8,222.90
in general payments reported to CMS, 2019-2025
43 companies · $2,762 in 2025
The $2,762 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $719 · 2022: $1,157 · 2023: $2,145 · 2024: $1,439 · 2025: $2,762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,783 · Education: $301 · Travel and Lodging: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,782.72 |
| Education | $300.97 |
| Travel and Lodging | $263.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,191.57 | 2022-2024 | Axonics |
| Sumitomo Pharma America, INC. | $1,172.84 | 2023-2025 | Gemtesa, Orgovyx |
| Myriad Genetic Laboratories, INC. | $644.65 | 2022-2025 | Prolaris, Bracanalysis Cdx |
| Janssen Biotech, INC. | $515.33 | 2022-2025 | Erleada, Rybrevant, Carvykti |
| Boston Scientific Corporation | $486.08 | 2023-2025 | Axonics, Rezum Generator, Spaceoar Vue System - 10ml |
| Abbvie INC. | $383.36 | 2021-2023 | |
| Astellas Pharma US INC | $356.90 | 2021-2025 | Padcev |
| Antares Pharma, INC. | $334.16 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Procept Biorobotics Corporation | $325.71 | 2023-2025 | Aquabeam Robotic System |
| Endo USA, INC. | $260.55 | 2024-2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $219.25 | 2022-2024 | Xiaflex |
| Tolmar, INC. | $212.92 | 2023-2025 | Jatenzo, Eligard |
| Bayer Healthcare Pharmaceuticals INC. | $186.61 | 2025 | |
| Myovant Sciences INC. | $154.41 | 2021-2022 | |
| Urovant Sciences INC | $145.26 | 2022 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $141.60 | 2022-2025 | Gentlecath Glide |
| Medtronic, INC. | $129.03 | 2023-2025 | Interstim |
| Astrazeneca Pharmaceuticals LP | $122.31 | 2021 | |
| Seagen INC. | $122.09 | 2023 | Padcev |
| Amgen INC. | $115.61 | 2021 | |
| Progenics Pharmaceuticals, INC. | $103.20 | 2022-2025 | Pylarify |
| Teleflex LLC | $80.69 | 2025 | Urolift |
| Ferring Pharmaceuticals INC. | $75.92 | 2024-2025 | Adstiladrin |
| Convatec INC. | $68.35 | 2022-2023 | |
| Mayne Pharma Commercial LLC | $57.62 | 2021-2022 | |
| Pfizer INC. | $55.22 | 2023-2025 | |
| Bluewind Medical | $51.39 | 2025 | Revi |
| Bioprotect Medical, INC. | $49.18 | 2025 | Bioprotect Balloon Implant System |
| C. R. Bard, INC. & Subsidiaries | $49.12 | 2023 | Bard Urinary Drainage Bag |
| Galderma Laboratories, L.P. | $48.86 | 2021 | |
| Currax Pharmaceuticals LLC | $43.13 | 2021-2022 | |
| Halozyme INC | $42.52 | 2023 | |
| Emd Serono, INC. | $36.61 | 2025 | |
| Palette Life Sciences, INC. | $33.62 | 2022 | |
| Dendreon Pharmaceuticals LLC | $32.04 | 2025 | Provenge |
| Agiliti Surgical, INC. | $29.64 | 2025 | |
| Urogen Pharma, INC. | $28.71 | 2025 | |
| Abbott Laboratories | $23.75 | 2022 | |
| Lupin INC. | $20.10 | 2021 | |
| Civco Medical Instruments | $20.08 | 2024 | |
| Azurity Pharmaceuticals, INC. | $19.81 | 2024 | Azmiro |
| Tolmar Pharmaceuticals, INC. | $17.31 | 2022 | |
| Avion Pharmaceuticals | $15.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Sheffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.